Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Colorcon
Merck
Express Scripts
Dow

Last Updated: July 2, 2022

Isopropyl alcohol - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for isopropyl alcohol and what is the scope of patent protection?

Isopropyl alcohol is the generic ingredient in one branded drug marketed by Zurex Pharma and is included in one NDA. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Isopropyl alcohol has sixty-five patent family members in twenty-two countries.

There is one drug master file entry for isopropyl alcohol.

Summary for isopropyl alcohol
Recent Clinical Trials for isopropyl alcohol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
State University of New York at BuffaloPhase 2/Phase 3
DSM Nutritional Products, Inc.Phase 2
University of Missouri-ColumbiaPhase 4

See all isopropyl alcohol clinical trials

US Patents and Regulatory Information for isopropyl alcohol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zurex Pharma ZURAGARD isopropyl alcohol SOLUTION;TOPICAL 210872-001 Apr 26, 2019 DISCN Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Zurex Pharma ZURAGARD isopropyl alcohol SOLUTION;TOPICAL 210872-001 Apr 26, 2019 DISCN Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Zurex Pharma ZURAGARD isopropyl alcohol SOLUTION;TOPICAL 210872-001 Apr 26, 2019 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for isopropyl alcohol

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1448186 C300550 Netherlands See Plans and Pricing PRODUCT NAME: MENGSEL VAN CATECHOLEN GEISOLEERD UIT EEN EXTRACT VAN GROENE THEE, CAMELLIA SINENSIS, L. O. KUNTZE MET ISOPROPYLMYRISTAAT; NATL. REGISTRATION NO/DATE: RVG 110904 20120920; FIRST REGISTRATION: DE 73486.00.00 20090831
0364417 SPC/GB97/014 United Kingdom See Plans and Pricing PRODUCT NAME: LATANOPROST (I.E. 13,14-DIHYDRO-17-PHENYL-18,19,20-TRINOR-PGF-ALPHA-ISOPROPYLESTER); NAT. REGISTRATION NO/DATE: 00032/0220 19961216; FIRST REGISTRATION: SE 12716 19960718; SPC EXTENSION AUTHORISATION: PL00057/1057-008 20101216
0289349 SPC/GB04/007 United Kingdom See Plans and Pricing PRODUCT NAME: ISOPROPYL(+)-(Z)-7-((1R,2R,3R,5S)-3,5-DIHYDROXY-2-(3-OXODECYL)CYCLOPENTYL)-5-HEPTENOATE; REGISTERED: CH 55634 01 20010329; UK PL00101/0667 20031112
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Mallinckrodt
Boehringer Ingelheim
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.